CoChat

Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF -mutant stage II and III colon cancer

Dunne, Philip D., Coleman, Helen G., Bankhead, Peter, Alderdice, Matthew, Gray, Ronan T., McQuaid, Stephen, Bingham, Victoria, Loughrey, Maurice B., James, Jacqueline A., McCorry, Amy M.B., Gilmore, Alan, Holohan, Caitriona, Klingbiel, Dirk, Tejpar, Sabine, Johnston, Patrick G., McArt, Darragh G., Nicolantonio, Federica Di, Longley, Daniel B., Lawler, Mark · 2018 · Oncotarget

Published version of a preprint

Cited by 10

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.24481

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 16

  1. Yatabe, 2010, Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer, FEBS J, 277, 301, 10.1111/j.1742-4658.2009.07448.x · DOI · Paper page
  2. Lebbe, 2011, Improved survival with vemurafenib in melanoma with BRAF V600E mutation, N Engl J Med, 364, 2507, 10.1056/NEJMoa1103782 · DOI · Paper page
  3. Bernards, 2012, Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR, Nature, 483, 100, 10.1038/nature10868 · DOI · Paper page
  4. Kalisky, 2016, CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer, N Engl J Med, 374, 211, 10.1056/NEJMoa1506597 · DOI · Paper page
  5. Kang, 2015, Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients, World J Gastroenterol, 21, 1457, 10.3748/wjg.v21.i5.1457 · DOI
  6. Lugli, 2010, Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis, Int J Cancer, 127, 367, 10.1002/ijc.25042 · DOI · Paper page
  7. Wei, 2011, Prognostic significance of Bcl-xL gene expression in human colorectal cancer, Acta Histochem, 113, 810, 10.1016/j.acthis.2011.01.002 · DOI
  8. Bussey, 1958, The spread of rectal cancer and its effect on prognosis, Br J Cancer, 12, 309, 10.1038/bjc.1958.37 · DOI · Paper page
  9. Letai, 2006, Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members, Cancer Cell, 9, 351, 10.1016/j.ccr.2006.03.027 · DOI · Paper page
  10. Corbett, 2017, Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics, Cancer Cell, 31, 142, 10.1016/j.ccell.2016.11.011 · DOI · Paper page
  11. Slaby, 2016, Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer, Oncotarget, 7, 622, 10.18632/oncotarget.5807 · DOI · Paper page
  12. Pantel, 2015, Disseminated Tumor Cells Persist in the Bone Marrow of Breast Cancer Patients through Sustained Activation of the Unfolded Protein Response, Cancer Res, 75, 5367, 10.1158/0008-5472.CAN-14-3728 · DOI
  13. Brandt, 2010, Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients, J Proteome Res, 9, 3158, 10.1021/pr100039d · DOI
  14. Yang, 2013, Uncovering a key to the process of metastasis in human cancers: a review of critical regulators of anoikis, J Cancer Res Clin Oncol, 139, 1795, 10.1007/s00432-013-1482-5 · DOI
  15. Simon, 2015, The consensus molecular subtypes of colorectal cancer, Nat Med, 21, 1350, 10.1038/nm.3967 · DOI · Paper page
  16. Hamilton, 2017, QuPath: Open source software for digital pathology image analysis, Sci Rep, 7, 16878, 10.1038/s41598-017-17204-5 · DOI · Paper page

Cited by

Metadata

Authors
Dunne, P. D., Coleman, H. G., Bankhead, P., Alderdice, M., Gray, R. T., McQuaid, S., Bingham, V., Loughrey, M. B., James, J. A., McCorry, A. M. B., Gilmore, A., Holohan, C., Klingbiel, D., Tejpar, S., Johnston, P. G., McArt, D. G., Nicolantonio, F. D., Longley, D. B., & Lawler, M.
Venue
Oncotarget
Published
2018-02-13
Volume
9
Issue
17
Pages
13834-13847
ISSN
1949-2553
Cited by
10
References
8
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.